Meditrial provides rapid workflows to rescue clinical trials during pandemic

2024-02-29T13:46:29+00:00March 19th, 2020|Categories: Clinical Trial, Covid-19, Europe, Innovation|Tags: , , , , |

As the COVID-19 emergency impacts all healthcare sectors, Meditrial provides rapid tools to help industry and researchers rescue their clinical trials. Safeguard of patients’ safety is the key concern, but also avoiding the compromise integrity of important studies due [...]

ITALY activates safeguard procedures for clinical trials during pandemic

2024-02-26T12:32:21+00:00March 19th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

The Italian Medicines Agency provides indications regarding the management of clinical trials in Italy during the COVID-19 (coronavirus disease 19) emergency. The guidelines describe the measures to manage clinical trials during the emergency and the exemptions granted. Download in [...]

GERMANY: BfArM provides support for ongoing clinical trials

2024-02-26T11:10:55+00:00March 18th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

Germany reacts to the pandemic with high attention to ongoing clinical trials. According to the government authority BfArM, protocol deviations and changes may occur with the dynamic risk situation and restrictions due to Coronavirus SARS-CoV-2. A dedicated email, CT-COVID@bfarm.de, [...]

MEDITRIAL HELPLINE SUPPORTS CLINICAL TRIALS DURING COVID-19 EMERGENCY

2024-02-29T10:24:48+00:00March 17th, 2020|Categories: Clinical Trial, Covid-19, Europe, Innovation|Tags: , , , , |

As your reliable and trustworthy partner, we at Meditrial, have taken extraordinary measures to be always at your side and support you and your peers during the time of the COVID-19 emergency. That´s why we set up a Meditrial FREE [...]

Czech Republic Authority SÚKL issues clinical trial instructions for subject safety and data validity during COVID-19 emergency

2024-02-02T10:16:28+00:00March 16th, 2020|Categories: Eastern Europe, Europe|Tags: , , , , , |

The Czech Authority  State Institute for Drug Control (SÚKL) has issued an opinion on a clinical research under current COVID-19 pandemic on 13 March and provided additional clarifications regarding the management of patients visits and study products on 16 [...]

Go to Top